Einträge von Wachtel, H. auf dem Publikationsserver

Löschmann, P. A., Lange, Klaus W., Wachtel, H. und Turski, L. (1994) MPTP-induced degeneration: interference with glutamatergic toxicity. Journal of neural transmission. Supplementum supl 43, S. 133-143.

Lange, Klaus W., Löschmann, P. A., Sofic, E., Burg, M., Horowski, R., Kalveram, K. T., Wachtel, H. und Riederer, Peter (1993) The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates. Naunyn-Schmiedeberg's archives of pharmacology 348 (6), S. 586-592.

Lange, Klaus W., Löschmann, P. A., Wachtel, H., Horowski, R., Jähnig, P., Jenner, P. und Marsden, C. D. (1992) Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets. European journal of pharmacology 212 (2-3), S. 247-252.

Löschmann, P. A., Lange, Klaus W., Kunow, M., Rettig, K. J., Jähnig, P., Honoré, T., Turski, L., Wachtel, H., Jenner, P. und Marsden, C. D. (1991) Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section 3 (3), S. 203-213.